Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, azithromycin dihydrate (Azyter®) cannot be endorsed for use within NHS Wales for local antibacterial treatment of conjunctivitis caused by susceptible strains: purulent bacterial conjunctivitis and trachomatous conjunctivitis caused by Chlamydia trachomatis. Please refer to the AWMSG position statement on the appraisal of antimicrobial medicines. |
||
|
||
Medicine details |
||
| Medicine name | azithromycin dihydrate (Azyter®) | |
| Formulation | 15 mg/g eye drops | |
| Reference number | 1176 | |
| Indication | For local antibacterial treatment of conjunctivitis caused by susceptible strains: purulent bacterial conjunctivitis and trachomatous conjunctivitis caused by Chlamydia trachomatis. |
|
| Company | Spectrum Thea Pharmaceuticals | |
| BNF chapter | Eye | |
| Assessment type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 02/11/2011 | |
| Further information AWMSG position statement on the appraisal of antimicrobial medicines |
||